agilon health director granted 2,133 RSUs
Battaglia Silvana reported acquisition or exercise transactions in this Form 4 filing. agilon health, inc. director Silvana Battaglia received an equity award of 2,133 restricted stock units, granted at no cash cost and reported as Common Stock.
Rhea-AI Filing Summary
Battaglia Silvana reported acquisition or exercise transactions in this Form 4 filing.
agilon health, inc. director Silvana Battaglia received an equity award of 2,133 restricted stock units, granted at no cash cost and reported as Common Stock. These RSUs vest in full on June 2, 2027, if she continues serving as a director. Following this grant, her beneficial ownership is 7,926 shares, which includes restricted stock units and reflects a 1-for-25 reverse stock split that became effective on March 30, 2026.
Positive
- None.
Negative
- None.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock | 2,133 | $0.00 | $0.00 |
Footnotes (3)
- F1. Restricted stock units that vest in full on June 2, 2027, subject to continued service as a director.
- F2. The amount of securities beneficially owned following the reported transaction reflects the 1 for 25 reverse stock split of the Issuer's issued and outstanding common stock effective March 30, 2026.
- F3. Includes restricted stock units.
Key Figures
Key Terms
restricted stock units financial
beneficially owned financial
reverse stock split financial
Common Stock financial
Grant, award, or other acquisition financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did Silvana Battaglia report in this agilon health (AGL) Form 4?
When do Silvana Battaglia’s new agilon health (AGL) RSUs vest?
Is Silvana Battaglia buying or selling agilon health (AGL) stock in this filing?
How does agilon health’s reverse stock split affect this Form 4 for AGL?
AI-generated analysis. How Rhea-AI works. Not financial advice.